Equashield Medical , Ltd.
EQUASHIELD is dedicated to providing healthcare professionals with safer, more efficient, and automated solutions for handling hazardous drugs. Their products include closed system transfer devices (CSTDs), pharmacy automation systems, and solutions for cell/gene therapy manufacturing, all designed to enhance safety and compliance in pharmaceutical practices. The company actively contributes to advancing safety standards through clinical studies, patents, and industry collaborations, emphasizing the importance of protecting healthcare workers from occupational exposure to hazardous substances. They also focus on staff education, long-term cost savings, and regulatory compliance, offering comprehensive training and ensuring their solutions meet regional regulations.
Industries
Nr. of Employees
large (251-1000)
Equashield Medical , Ltd.
Port Washington, New York, United States, North America
Patents
Products
Sealed syringe assemblies (multiple volumes)
Consumable syringe assemblies with an encapsulated plunger and closed sterile air chamber engineered to enable pressure equalization without open air exchange; offered in multiple volumetric sizes to support compounding and administration.
Sealable vial adapters and IV spike adapters
Adapters designed to enable repeated, leak‑resistant access for withdrawal, reconstitution and infusion while minimizing microbial ingress and handling steps.
IV tubing sets and multi‑drug administration sets
IV tubing and multi‑component administration sets that enable secure, leak‑resistant multi‑drug delivery and reduce component count to streamline transitions between drugs during infusion.
Automated compounding platform with integrated closed-transfer interfaces
Compact automated compounding system providing end‑to‑end sealed transfer connections, robotic reconstitution and filling stations, embedded cameras and machine vision, AI‑based dose verification, and complete electronic traceability from order to administration (reported throughput up to 37 doses/hour).
Containment consumables for cell and gene therapy manufacturing
Sealed transfer connectors and single‑use containment adaptors engineered for aseptic transfers in cellular and gene therapy production to reduce contamination risk during critical handling steps.
Sealed syringe assemblies (multiple volumes)
Consumable syringe assemblies with an encapsulated plunger and closed sterile air chamber engineered to enable pressure equalization without open air exchange; offered in multiple volumetric sizes to support compounding and administration.
Sealable vial adapters and IV spike adapters
Adapters designed to enable repeated, leak‑resistant access for withdrawal, reconstitution and infusion while minimizing microbial ingress and handling steps.
IV tubing sets and multi‑drug administration sets
IV tubing and multi‑component administration sets that enable secure, leak‑resistant multi‑drug delivery and reduce component count to streamline transitions between drugs during infusion.
Automated compounding platform with integrated closed-transfer interfaces
Compact automated compounding system providing end‑to‑end sealed transfer connections, robotic reconstitution and filling stations, embedded cameras and machine vision, AI‑based dose verification, and complete electronic traceability from order to administration (reported throughput up to 37 doses/hour).
Containment consumables for cell and gene therapy manufacturing
Sealed transfer connectors and single‑use containment adaptors engineered for aseptic transfers in cellular and gene therapy production to reduce contamination risk during critical handling steps.
Services
Delivery of webinars, instructional videos, virtual simulators, documentation and on‑site or remote training to support safe handling of hazardous drugs and correct use of closed transfer consumables.
Collaborative support for designing and conducting peer‑reviewed clinical, sterility and surface contamination studies, including protocol development, sampling methodologies and dissemination of results.
Operational assistance for deployment of automated compounding systems and sealed-transfer consumables including installation, equipment qualification, software integration, validation and on‑site commissioning.
Evaluation services that assess device compatibility with existing equipment, predict extractable doses using DVO methods, and model financial impact including extended vial use and occupational exposure cost mitigation.
Delivery of webinars, instructional videos, virtual simulators, documentation and on‑site or remote training to support safe handling of hazardous drugs and correct use of closed transfer consumables.
Collaborative support for designing and conducting peer‑reviewed clinical, sterility and surface contamination studies, including protocol development, sampling methodologies and dissemination of results.
Operational assistance for deployment of automated compounding systems and sealed-transfer consumables including installation, equipment qualification, software integration, validation and on‑site commissioning.
Evaluation services that assess device compatibility with existing equipment, predict extractable doses using DVO methods, and model financial impact including extended vial use and occupational exposure cost mitigation.
Expertise Areas
- Containment engineering for hazardous drug transfer
- Automated sterile compounding and workflow integration
- Clinical and environmental validation of containment systems
- Regulatory compliance for device-based containment solutions
Key Technologies
- Closed‑system transfer device technology
- Closed‑back syringe architecture
- Sealable vial and spike adapters
- Standardized luer connector systems
News & Updates
Hospitals in Southwest Germany have transitioned to EQUASHIELD’s CSTD to enhance safety in handling hazardous drugs, reporting improved staff satisfaction, reduced contamination, and streamlined workflows.
The EU OSHA update highlights new safety regulations for healthcare workers handling hazardous medicinal products, emphasizing the use of closed systems and CSTDs like EQUASHIELD.
The EQUASHIELD Syringe Unit received additional FDA clearance for full volume use, marking a milestone as the most used CSTD in the USA for five consecutive years.
Hospitals in Southwest Germany have transitioned to EQUASHIELD’s CSTD to enhance safety in handling hazardous drugs, reporting improved staff satisfaction, reduced contamination, and streamlined workflows.
The EU OSHA update highlights new safety regulations for healthcare workers handling hazardous medicinal products, emphasizing the use of closed systems and CSTDs like EQUASHIELD.
The EQUASHIELD Syringe Unit received additional FDA clearance for full volume use, marking a milestone as the most used CSTD in the USA for five consecutive years.